UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000047146 |
|---|---|
| Receipt number | R000053781 |
| Scientific Title | The modulation of spinal pathways at rest, standing, and during walking |
| Date of disclosure of the study information | 2022/03/11 |
| Last modified on | 2022/03/11 03:44:08 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The modulation of spinal pathways during walking
Acronym
The modulation of spinal pathways during walking
Scientific Title
The modulation of spinal pathways at rest, standing, and during walking
Scientific Title:Acronym
The modulation of spinal pathways at rest, standing, and during walking
Region
| Japan |
Condition
Condition
Healthy adults
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To investigate the modulation of spinal pathways at rest, standing, and during walking
Basic objectives2
Bio-availability
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Electrophysiological assessment of spinal reciprocal inhibition and heteronymous pathways
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 50 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Person who have received a sufficient explanation for participating in this study and have obtained written consent with sufficient understanding
Key exclusion criteria
History of orthopedic or neurological disorder
Target sample size
20
Research contact person
Name of lead principal investigator
| 1st name | Yoko |
| Middle name | |
| Last name | Takahashi |
Organization
Juntendo University
Division name
Faculty of Health Science
Zip code
113-0033
Address
3-2-12, Hongo, Bunkyo-ku, Tokyo
TEL
03-3813-3111
y.takahashi.jk@juntenco.ac.jp
Public contact
Name of contact person
| 1st name | Yoko |
| Middle name | |
| Last name | Takahashi |
Organization
Juntendo University
Division name
Faculty of Health Science
Zip code
113-0033
Address
3-2-12, Hongo, Bunkyo-ku, Tokyo
TEL
03-3813-3111
Homepage URL
y.takahashi.jk@juntendo.ac.jp
Sponsor or person
Institute
Juntendo University
Institute
Department
Personal name
Funding Source
Organization
Juntendo Univeristy
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Research Ethics Committee, Faculty of Health Science
Address
3-2-12, Hongo, Bunkyo-ku, Tokyo
Tel
03-3813-3111
y.tatakashi.jk@juntendo.ac.jp
Secondary IDs
Secondary IDs
YES
Study ID_1
21-012
Org. issuing International ID_1
Research Ethics Committee, Faculty of Health Science
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2022 | Year | 03 | Month | 11 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2021 | Year | 07 | Month | 30 | Day |
Date of IRB
| 2021 | Year | 12 | Month | 07 | Day |
Anticipated trial start date
| 2021 | Year | 12 | Month | 10 | Day |
Last follow-up date
| 2024 | Year | 09 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Evaluation of spinal reciprocal inhibition and heteronymous pathways at rest, standing, and during walking
Pilot data for future investigation in patients with stroke
Management information
Registered date
| 2022 | Year | 03 | Month | 11 | Day |
Last modified on
| 2022 | Year | 03 | Month | 11 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053781
